Tags

Type your tag names separated by a space and hit enter

Quality of life and new devices in the management of type 1 diabetes in children and adolescents.
Acta Biomed. 2003; 74 Suppl 1:21-5.AB

Abstract

Insulin therapy is the cornerstone in treatment of type 1 diabetes in children and adolescents. In order to prevent long-term complication multiple daily injections (MDI) are required. Quality of life is dearly affected by the administrations of 3-4 daily injections with syringe. Insulin pens are new devices realized with the aim of simplifying insulin administration. More recently continuous blood sugar monitoring has become available for clinical studies and its role for better metabolic control and quality of life is now under investigation. The aim of this paper is to review published data on the significance of insulin pen and continuous blood sugar monitoring on quality of life in diabetic children and adolescents.

Authors+Show Affiliations

Department of Paediatrics, Endocrine Unit, Scientific Institute H San Raffaele, Università Vita-Salute, Milan, Italy.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Evaluation Study
Journal Article

Language

eng

PubMed ID

12817797

Citation

Piscopo, Maria Antonietta, et al. "Quality of Life and New Devices in the Management of Type 1 Diabetes in Children and Adolescents." Acta Bio-medica : Atenei Parmensis, vol. 74 Suppl 1, 2003, pp. 21-5.
Piscopo MA, Chiesa G, Bonfanti R, et al. Quality of life and new devices in the management of type 1 diabetes in children and adolescents. Acta Biomed. 2003;74 Suppl 1:21-5.
Piscopo, M. A., Chiesa, G., Bonfanti, R., Viscardi, M., Meschi, F., & Chiumello, G. (2003). Quality of life and new devices in the management of type 1 diabetes in children and adolescents. Acta Bio-medica : Atenei Parmensis, 74 Suppl 1, 21-5.
Piscopo MA, et al. Quality of Life and New Devices in the Management of Type 1 Diabetes in Children and Adolescents. Acta Biomed. 2003;74 Suppl 1:21-5. PubMed PMID: 12817797.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Quality of life and new devices in the management of type 1 diabetes in children and adolescents. AU - Piscopo,Maria Antonietta, AU - Chiesa,Gaia, AU - Bonfanti,Riccardo, AU - Viscardi,Matteo, AU - Meschi,Franco, AU - Chiumello,Giuseppe, PY - 2003/6/24/pubmed PY - 2003/7/19/medline PY - 2003/6/24/entrez SP - 21 EP - 5 JF - Acta bio-medica : Atenei Parmensis JO - Acta Biomed VL - 74 Suppl 1 N2 - Insulin therapy is the cornerstone in treatment of type 1 diabetes in children and adolescents. In order to prevent long-term complication multiple daily injections (MDI) are required. Quality of life is dearly affected by the administrations of 3-4 daily injections with syringe. Insulin pens are new devices realized with the aim of simplifying insulin administration. More recently continuous blood sugar monitoring has become available for clinical studies and its role for better metabolic control and quality of life is now under investigation. The aim of this paper is to review published data on the significance of insulin pen and continuous blood sugar monitoring on quality of life in diabetic children and adolescents. SN - 0392-4203 UR - https://www.unboundmedicine.com/medline/citation/12817797/Quality_of_life_and_new_devices_in_the_management_of_type_1_diabetes_in_children_and_adolescents_ L2 - https://www.diseaseinfosearch.org/result/2236 DB - PRIME DP - Unbound Medicine ER -